CABA
Cabaletta Bio, Inc.
+0.03 (+1.41%)2.53USD1.8M成交股數428M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 44.4M | 37.4M | 36.2M | 39.8M | 37.6M | 29.0M | 26.3M | 23.4M | 22.0M | 17.4M | 13.8M | 11.8M |
| 銷售管理費用 | 7.6M | 6.9M | 6.4M | 6.8M | 8.3M | 8.1M | 6.8M | 6.9M | 6.1M | 5.7M | 4.9M | 4.1M |
| 營業利益 | −52.0M+13% | −44.3M+19% | −42.6M+29% | −46.6M+54% | −45.9M+64% | −37.1M+60% | −33.0M+77% | −30.3M+91% | −28.0M | −23.1M | −18.7M | −15.9M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −51.0M+13% | −43.5M+21% | −41.9M+37% | −44.9M+63% | −45.1M+80% | −35.9M+72% | −30.6M+86% | −27.6M+91% | −25.0M | −20.9M | −16.4M | −14.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.34-53% | -0.39-45% | -0.22-65% | -0.44-21% | -0.73+43% | -0.71+54% | -0.62+68% | -0.56+51% | -0.51 | -0.46 | -0.37 | -0.37 |
| 稀釋股數 | 151M | 112M | – | – | 61.9M | 50.7M | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 225M | 117M | 83.0M | 60.2M | 146M | 132M | 171M | 179M | 175M | 193M | 116M | 128M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 257M | 148M | 165M | 190M | 225M | 165M | 204M | 217M | 240M | 254M | 173M | 185M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 46.1M | 44.8M | 53.0M | 50.3M | 46.0M | 43.6M | 30.2M | 17.9M | 18.7M | 17.5M | 12.4M | 10.5M |
| 股東權益 | 211M | 103M | 112M | 139M | 178M | 122M | 174M | 200M | 222M | 236M | 161M | 174M |
| 負債比 | 18.0% | 30.3% | 32.1% | 26.5% | 20.5% | 26.4% | 14.8% | 8.2% | 7.8% | 6.9% | 7.1% | 5.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −42.6M+38% | – | – | – | −30.8M | – | – | −24.0M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 785K | – | – | 812K | – | – | – |
| 自由現金流 | – | −42.6M+35% | – | – | – | −31.6M | – | – | −24.8M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −168M | –% | -2.10 | −132M |
| FY2024 | – | – | −116M | –% | -2.34 | −90.4M |
| FY2023 | – | – | −67.7M | –% | -1.65 | −54.2M |
| FY2022 | – | – | −53.0M | –% | -1.81 | −48.8M |
| FY2021 | – | – | −46.3M | –% | -1.80 | −35.3M |
| FY2020 | – | – | −33.3M | –% | -1.44 | −27.4M |
| FY2019 | – | – | −16.9M | –% | -4.07 | −16.7M |
| FY2018 | – | – | −12.2M | –% | -6.87 | – |